Glycosmedia

Diabetes News Service

  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

“Attitudes to obesity” findings from the 2015 survey

January 16th 2017

In 2015, Public Health England commissioned four sets of questions on NatCen’s British Social Attitudes (BSA) survey, one of which focused on obesity. The BSA is an authoritative, high quality source of data on views of the British public which has been performed annually since 1983. It uses random probability sampling to yield a representative sample of adults aged 18 years and older who live in private households. The majority of questions are asked by an interviewer face-to-face in the form of a Computer Assisted Personal Interview, while a smaller number are answered by respondents in a self-completion booklet.

“Attitudes to obesity” is the publication of the obesity findings from the 2015 survey, presenting new findings on attitudes towards obesity and what might be done to reduce its prevalence. Despite appreciating some of the health risks, people tended not to recognise obesity when present, especially in men. Obesity was typically regarded as a problem for individuals and health care professionals rather than society in general. Furthermore, those who are obese were often stigmatised.

The findings are particularly relevant to type 2 diabetes (T2DM) since obesity is widely seen as the driver behind the T2DM ‘epidemic’. Regarding obesity as individual issue, implies that people are personally responsible for their plight and this is then extrapolated to blame following a diagnosis of T2DM. In this environment, the political imperative to allow for new ‘expensive’ treatments to be made available to people with T2DM is low. Indeed, a new definition of ‘expensive’ comes into play, where the individual per-person drug cost is subsumed by the population cost because of the large numbers involved. On this basis, one can argue that people with T2DM are discriminated against, compared with other conditions such as cancer, heart disease and liver disorders.

Fortunately, the survey showed significant support for actions aimed at reducing levels of obesity. We need to make sure that our patients with T2DM can also tap into this support.

Professor Steve Bain

Categories: Updates

Diabetes Updates Archive

calendar-iconDiabetes Updates Archive ››

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsor

Sanofi Diabetes

Gold Sponsors

Napp DiabetesNovo NordiskAstraZenecaMSDBoehringer Ingelheim Lilly

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Share Glycosmedia

Follow us on Twitter

My Tweets

Glycosmedia App

mobileA Glycosmedia iPhone/iPad App is available FREE from the iTunes store.


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


HONcode Standard

HONConduct783211_s2This site complies with the HONcode standard for trustworthy health information: verify here.

Copyright © 2018 Glycosmedia Partnership